Dr. Sharma is a Clinical Genomics Director and product manager at PierianDx, in charge of both Interpretation Services and the Gateway Program. Prior to PierianDx, he worked for nine years at the Genomic and Pathology Services and the Center for Biomedical Informatics at Washington University School of Medicine where he was a Project Manager and Instructor wherein he designed, planned, and validated NGS tests and their implementation. Additionally, he has experience managing clinical trials, NGS data analysis, and creating testing infrastructures for usage in the laboratory. He holds a Ph.D. in Molecular and Cell Biology from Dalhousie University in Halifax, Nova Scotia, Canada. In his postdoctoral research, he studied molecular genetic changes and relevant biomarkers associated with the formation and progression of brain tumors and inherited cancer syndrome.
At PierianDx, he is responsible for managing variant analysis teams and developing a portfolio of assays to be offered as turn-key, full-service offerings to customers as a jump-start to their own clinical operations or as a long-term send-out solution.